Search Results - "Oliveira, Jaqueline C"

Refine Results
  1. 1

    Long non‐coding RNAs differential expression in breast cancer subtypes: What do we know? by Mathias, Carolina, Zambalde, Erika P., Rask, Philip, Gradia, Daniela F., de Oliveira, Jaqueline C.

    Published in Clinical genetics (01-05-2019)
    “…Breast Cancer (BC) is the most commonly diagnosed cancer and is the leading cause of cancer deaths in women. BC is a heterogeneous disease with different…”
    Get full text
    Journal Article
  2. 2

    Growth, nodulation, production, and physiology of leguminous plants in integrated production systems by Freitas, Igor C., Ferreira, Evander A., Alves, Matheus A., Oliveira, Jaqueline C., Frazão, Leidivan A.

    Published in Agrosystems, geosciences & environment (01-03-2023)
    “…Choosing the species suitable for cultivation in intercropped systems is a critical limiting factor for grain and forage production. This study aimed to…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Long Non-Coding RNAs in Multifactorial Diseases: Another Layer of Complexity by Cipolla, Gabriel A, de Oliveira, Jaqueline C, Salviano-Silva, Amanda, Lobo-Alves, Sara C, Lemos, Debora S, Oliveira, Luana C, Jucoski, Tayana S, Mathias, Carolina, Pedroso, Gabrielle A, Zambalde, Erika P, Gradia, Daniela F

    Published in Non-coding RNA (11-05-2018)
    “…Multifactorial diseases such as cancer, cardiovascular conditions and neurological, immunological and metabolic disorders are a group of diseases caused by the…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Long Non-Coding RNA TUG1 Expression Is Associated with Different Subtypes in Human Breast Cancer by Gradia, Daniela F, Mathias, Carolina, Coutinho, Rodrigo, Cavalli, Iglenir J, Ribeiro, Enilze M S F, de Oliveira, Jaqueline C

    Published in Non-coding RNA (20-12-2017)
    “…Taurine upregulated 1 gene ( ) is a long non-coding RNA associated with several types of cancer. Recently, differential expression of was found in cancerous…”
    Get full text
    Journal Article
  8. 8
  9. 9

    MicroRNA expression and activity in pediatric acute lymphoblastic leukemia (ALL) by de Oliveira, Jaqueline C., Brassesco, María Sol, Scrideli, Carlos Alberto, Tone, Luiz Gonzaga, Narendran, Aru

    Published in Pediatric blood & cancer (01-10-2012)
    “…Acute lymphoblastic leukemia (ALL) is the most common type of pediatric neoplasia. Highly heterogeneous, ALL includes several genetic subtypes with varying…”
    Get full text
    Journal Article
  10. 10
  11. 11

    YM155 induces apoptosis in p53-deficient T-acute lymphoblastic leukemia cells independent of survivin inhibition by Sales, Leilane, de Sousa, Graziella R, Ferreira-Silva, Guilherme Á, Castro-Gamero, Angel M, Ionta, Marisa, de Oliveira, Jaqueline C

    Published in Anti-cancer drugs (01-03-2017)
    “…T-acute lymphoblastic leukemia (T-ALL) is an aggressive hematological cancer that arises from the malignant transformation of T-cell progenitors. Despite the…”
    Get full text
    Journal Article
  12. 12

    Cytostatic in vitro Effects of DTCM-Glutarimide on Bladder Carcinoma Cells by Brassesco, Maria S, Pezuk, Julia A, Morales, Andressa G, De Oliveira, Jaqueline C, Valera, Elvis T, Da Silva, Glenda N, De Oliveira, Harley F, Scrideli, Carlos A, Umezawa, Kazuo, Tone, Luiz G

    “…Bladder cancer is a common malignancy worldwide. Despite the increased use of cisplatin-based combination therapy, the outcomes for patients with advanced…”
    Get full text
    Journal Article
  13. 13

    BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity by Morales, Andressa G, Brassesco, María S, Pezuk, Julia A, Oliveira, Jaqueline C, Montaldi, Ana P, Sakamoto-Hojo, Elza T, Scrideli, Carlos A, Tone, Luiz G

    Published in Anti-cancer drugs (01-11-2011)
    “…Osteosarcoma is the most common primary malignant tumor of bone, which frequently occurs in the second decade of life. Despite the improvements in neoadjuvant…”
    Get full text
    Journal Article
  14. 14

    MicroRNA-100 acts as a tumor suppressor in human bladder carcinoma 5637 cells by Oliveira, Jaqueline C, Brassesco, María S, Morales, Andressa G, Pezuk, Julia A, Fedatto, Paola Fernanda, da Silva, Glenda N, Scrideli, Carlos A, Tone, Luiz G

    “…Bladder carcinoma is one of the most common tumors in the world and despite the therapy currently available most of the patients relapse. Better understanding…”
    Get more information
    Journal Article
  15. 15

    Antiproliferative in vitro effects of BI 2536-mediated PLK1 inhibition on cervical adenocarcinoma cells by Pezuk, Julia A., Brassesco, María Sol, Oliveira, Jaqueline C., Morales, Andressa G., Montaldi, Ana P., Sakamoto-Hojo, Elza T., Scrideli, Carlos A., Tone, Luiz G.

    Published in Clinical and experimental medicine (01-02-2013)
    “…Cervical adenocarcinoma is one of the most common gynecological malignancies. Despite the improvements in multimodality treatment, advanced disease is still…”
    Get full text
    Journal Article
  16. 16

    Cytostatic in vitro effects of DTCM-glutarimide on bladder carcinoma cells by Brassesco, María S, Pezuk, Julia A, Morales, Andressa G, de Oliveira, Jaqueline C, Valera, Elvis T, da Silva, Glenda N, de Oliveira, Harley F, Scrideli, Carlos A, Umezawa, Kazuo, Tone, Luiz G

    “…Bladder cancer is a common malignancy worldwide. Despite the increased use of cisplatin-based combination therapy, the outcomes for patients with advanced…”
    Get full text
    Journal Article
  17. 17

    Cell Lines Molecular Classification by FT-IR Spectroscopy Using the Recurrence Quantification Analysis (RQA) Technique by Powrosnek, Leticia C. B., Coninck, Jose Carlos P., Antoniassi, Marcelo, Kamikawachi, Ricardo C., Veiga, Rafaela N., de Oliveira, Jaqueline C.

    “…In this work, we verified how Recurrence quantification analysis (RQA) can help and improve the analysis of profiles and patterns in the cell lines spectra…”
    Get full text
    Conference Proceeding
  18. 18
  19. 19
  20. 20